EAU 2013 - Programme Book - YouMed

188 Salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence
and imaging-detected nodal metastases
N. Suardi, J.R. Karnes, S. Joniau, K.A. Touijer, D. Osmonov, A. Aksenov, A. Briganti, P. Rigatti, H. Van
Poppel, K.P. Jünemann (Milan, Italy; Rochester, New York, United States of America; Leuven, Belgium; Kiel,
Germany)
189 Is a fatal family history or the apparent mode of disease transmission of prostate cancer a prognostic
factor for survival?
K. Herkommer, E. Donel, J.E. Gschwend, M. Kron (Munich, Ulm, Germany)
190 Radical prostate cancer therapy is associated with a survival benefit in the older man
J. Cathcart, J. Van Der Meulen (London, United Kingdom)
191 High-dose intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: Toxicity and
early clinical outcome
V. Fonteyne, N. Lumen, C. Van Praet, P. Ost, K. Decaestecker, G. De Meerleer (Ghent, Belgium)
192 The 10-years follow-up of the ARO 96-02/AUO AP 09/95 trial on adjuvant radiotherapy (ART) versus waitand-see
(WS) after prostatectomy for pT3 cancer – subgroup analysis
T. Wiegel, D. Bottke, D. Bartkowiak, C. Bronner, U. Steiner, A. Siegmann, R. Golz, S. Störkel, N. Willich,
A. Semjonow, M. Stöckle, C. Rübe, P. Althaus, U. Rebmann, T. Kälble, H.J. Feldmann, M. Wirth, A. Hinke,
W. Hinkelbein, K. Miller (Ulm, Berlin, Wuppertal, Münster, Homburg Saar, Dessau, Fulda, Dresden,
Langenfeld, Germany)
Discussion on poster 192
A. Bossi, Villejuif (FR)
EAU Milan 2013
129
Saturday